过去一年中添加的文章,按日期排序

[HTML][HTML] Cyclosporin A as an Add-On Therapy to a Corticosteroid-Based Background Treatment in Patients with COVID-19: A Multicenter, Randomized Clinical Trial

L Llanos Jiménez, B Alvarez-Alvarez… - Journal of Clinical …, 2024 - mdpi.com
5 天前 - … The search of adjuvant immunomodulatory therapies has been ongoing ever since
the … -on therapy to the standard of care (SoC) in patients with severe COVID-19 pneumonia. …

Add-on hemoperfusion in SARS-CoV-2-infected pregnant patients: a case series

S Chiewroongroj, T Naorungroj, R Ratanarat - Journal of Medical Case …, 2024 - Springer
6 天前 - … severe COVID-19 to demonstrate the utilization of HP as an adjunctive therapy
during … in pregnant patients when standard immunomodulatory therapy is contraindicated or …

Proteomics and COVID-19: Recent Trends

C Chandarana, V Prajapati, V Vashi, J Patel - … : Recent Trends and …, 2024 - Springer
8 天前 - … responses associated with COVID-19. Researchers have … the design of
immunomodulatory therapies and vaccines. … with post-COVID-19 conditions and active COVID-19

Potential Role of Tinospora Cordifolia in Management of COVID-19: A Systematic Review

R Singh, L Sharma - International journal of health sciences - neliti.com
9 天前 - … has pushed researcher towards alternative therapies. This review focuses on the
… of COVID-19 which can be benefitted with administration of Giloy. The immunomodulatory

Recent developments in the therapeutics of SARS-CoV-2 infection

P Nagu, A Parashar, P Sharma, V Mehta - One Health Bulletin, 2024 - journals.lww.com
11 天前 - … as a potential adjunct therapy in managing infectious diseases like COVID-19. While
… , anti-inflammatory and immunomodulatory roles of vitamins in COVID-19 therapy. Eur J …

[PDF][PDF] Decreased progenitor TCF1+ T-cells correlate with COVID-19 disease severity

R Kremer, C Mihalcioiu, CE Rudd - differentiation - d-nb.info
12 天前 - … Here, we show that severe COVID-19 disease involves a preferential decline in
the … of TCF1 + T-cells may contribute to the loss of T-cells in severe COVID-19 patients. …

[HTML][HTML] The Role of Natural Products in Immunopharmacology

G Accardi, D Di Majo, A Aiello - International Journal of Molecular …, 2024 - mdpi.com
13 天前 - … They focused on the immunomodulatory effects of CV’s polysaccharopeptides,
such as PSP and PSK, in cancer and viral infections, including COVID-19. The study …

MM-289 Exosomal Vesicles as a Promising Strategy for Severe COVID-19 in Multiple Myeloma Patients

Y Nouet, M Joshi, V Cortiana, G Pramil… - … Myeloma and Leukemia, 2024 - Elsevier
13 天前 - … anticancer therapy had a 55% higher mortality from symptomatic COVID-19. Given
their … CoV-2 viral entry and function as immunomodulators. Their ability to deliver therapeutic …

Unlocking the code for stroke treatment and care

Y Lou - Journal of Central Nervous System Disease, 2024 - journals.sagepub.com
17 天前 - … , with their immunomodulatory and tissue regenerative … their role in treating severe
COVID-19, a condition marked … clinical applicability of hPSC expansion for stroke therapy.…

Exploration of medicinal plants as potential therapeutics against COVID-19: molecular insights and drug development prospects with other significant medicinal …

S Dilip Bhandare - Journal of Pharmacy and Pharmacology, 2024 - academic.oup.com
19 天前 - therapies for combating COVID-19, offering promising avenues for treatment beyond
… of COVID-19 [6, 7]. Tinospora cordifolia, is renowned for its immunomodulatory effects. …